Targeting Ocular Disorders

Dr. Einar Stefansson, Oculis’ co-founder, will make a presentation at Cambridge Healthtech Institute’s fourth annual Targeting Ocular Disorders conference. The conference takes place on September 21-22, 2016 in Boston, MA.

Dr. Stefansson’s presentation, titled “Nanoparticle Eye-Drops Deliver Drugs to Retina in Human Patients” will discuss Oculis’ solubilizing nanoparticle (SNP) eye drop technology and is scheduled on September 20 at 3.15 PM under the section on innovative drug delivery methods for ocular disorders.

If you are interested in meeting Dr. Stefansson or other Oculis delegates, send an email to to arrange a meeting.